These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31 related articles for article (PubMed ID: 15701885)
21. TAS-108: a novel steroidal antiestrogen. Buzdar AU Clin Cancer Res; 2005 Jan; 11(2 Pt 2):906s-8s. PubMed ID: 15701885 [TBL] [Abstract][Full Text] [Related]
22. Phase I and II studies of toremifene. Hamm JT Oncology (Williston Park); 1997 May; 11(5 Suppl 4):19-22. PubMed ID: 9165502 [TBL] [Abstract][Full Text] [Related]
23. Pure oestrogen antagonists for the treatment of advanced breast cancer. Howell A Endocr Relat Cancer; 2006 Sep; 13(3):689-706. PubMed ID: 16954425 [TBL] [Abstract][Full Text] [Related]
24. Fulvestrant: pharmacokinetics and pharmacology. Robertson JF; Harrison M Br J Cancer; 2004 Mar; 90 Suppl 1(Suppl 1):S7-10. PubMed ID: 15094758 [TBL] [Abstract][Full Text] [Related]
25. Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review. Van de Wiele C; De Vos F; Slegers G; Van Belle S; Dierckx RA Eur J Nucl Med; 2000 Sep; 27(9):1421-33. PubMed ID: 11007529 [TBL] [Abstract][Full Text] [Related]